Exenatide Research
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes
Cardiovascular Diabetology·August 23, 2025
Cardiovascular outcomes analysis group
Summary
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes.
Study Details
Study Design
Post-hoc analysis of EXSCEL CVOT
Indication
Cardiovascular outcomes in T2D
Intervention
Exenatide once-weekly
Species
Human